SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Welcome to the POTP board, the DPP-IV company
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: rkrw who wrote (45)11/18/2006 7:08:44 PM
From: dr.praveen  Read Replies (2) of 90
 
Sorry for butting in.One sec I tried to forget that it is a vit analog and looked into the co for a few min. Here is what I feel:

The phase II results were sort of interesting. But the thing is the study's size and pr endpoint were acc to CK-MB of more than 50ng/ml. But when they assess it for the end point CK-MB of greater than 100ng/ml, I don't feel comfortable. So they have to find a partner, show the benefit in a few thousand pts like AGIX is doing now which makes the trial very risky from an investor point of view even if p3 succeeds.

Just my 2C:-)

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News